Brainsway’s Deep TMS Approved to Treat Depression, Schizophrenia

Brainsway Ltd. (BRIN) said Israel’s Health Ministry approved the company’s Deep TMS device to treat major depression, bipolar depression and schizophrenia, according to a statement filed today with the Tel Aviv Stock Exchange.

To contact the reporter on this story: Susan Lerner in Jerusalem at slerner2@bloomberg.net

To contact the editor responsible for this story: Jonathan Ferziger at jferziger@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.